FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Günter Henze

Research Profile

Disorders

Living Beings

Infants

Procedures

Phenomena

Recurrence

Concepts & Ideas

Chemicals & Drugs

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
Jenny Lena Kanitz; Alfred Längler; Kim Pretzer; Gabriele Calaminus; Pablo Hernáiz Driever; Günter Henze; Andreas Wiener; Georg Seifert
Eurythmy therapy in the aftercare of pediatric posterior fossa tumour survivors--a pilot study.
Joachim Köchling; Yvonne Rott; Michael Sagner; Manuel Schmidt; Hendrik Ungefroren; Burghard Wittig; Günter Henze
Can anthocyanins improve maintenance therapy of Ph(+) acute lymphoblastic leukaemia?
Cornelia Eckert; Gabriele Escherich; Tom W L Groeneveld; Thomas Klingebiel; Christina Peters; Martin Schrappe; Karl Seeger; Arend von Stackelberg; Arndt Borkhardt; Günter Henze
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Günter Henze (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jenny Lena Kanitz; Alfred Längler; Kim Pretzer; Gabriele Calaminus; Pablo Hernáiz Driever; Günter Henze; Andreas Wiener; Georg Seifert
Eurythmy therapy in the aftercare of pediatric posterior fossa tumour survivors--a pilot study.
Complementary therapies in medicine 2013;21 Suppl 1():S3-9.
2013: Joachim Köchling; Yvonne Rott; Michael Sagner; Manuel Schmidt; Hendrik Ungefroren; Burghard Wittig; Günter Henze
Can anthocyanins improve maintenance therapy of Ph(+) acute lymphoblastic leukaemia?
European journal of haematology 2013;90(4):291-300.
2013: Cornelia Eckert; Gabriele Escherich; Tom W L Groeneveld; Thomas Klingebiel; Christina Peters; Martin Schrappe; Karl Seeger; Arend von Stackelberg; Arndt Borkhardt; Günter Henze
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
European journal of cancer (Oxford, England : 1990) 2013;49(6):1346-55.
2013: Stefanie Krentz; Claudio Lottaz; A Mendioroz; Karl Seeger; R Vaggopoulou; Arend von Stackelberg; Gabriele Körner; P Dörge; Cornelia Eckert; J C Engelmann; T W L Groeneveld; Christian Hagemeier; Günter Henze; J Hof; Renate Kirschner-Schwabe
Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
Leukemia 2013;27(2):295-304.
2013: Georg Seifert; Katharina Witt; Günter Henze; Jenny-Lena Kanitz; Kim Pretzer; Sina Reulecke; Andreas Voss
Improvement of circadian rhythm of heart rate variability by eurythmy therapy training.
Evidence-based complementary and alternative medicine : eCAM 2013;2013():564340.
2012: Joachim Köchling; Christina Marschke; Yvonne Rott; Manuel Schmidt; Jürgen Westermann; Burghardt Wittig; Stefanie Arndt; Katrin Kalies; Günter Henze
Prevention and synergistic control of Ph(+) ALL by a DNA vaccine and 6-mercaptopurine.
Vaccine 2012;30(41):5949-55.
2012: Christian Furth; Oliver Großer; Hubertus Hautzel; Günter Henze; Frank Hofheinz; Patrick Hundsdoerfer; Robert M Meseck; Holger Amthauer; Timm Denecke; Stefan Schoenberger; Ingo Steffen; Juri Ruf
SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET?
Pediatric blood & cancer 2012;59(3):475-80.
2012: Gesche Tallen; Günter Henze; Arend von Stackelberg
[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing].
Pharmazie in unserer Zeit 2012;41(3):214-21.
2012: R Rendtorff; M Beyer; R Dittrich; Günter Henze; C Hohmann; Thomas Keil; A Müller; Anja Borgmann
Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors.
Andrologia 2012;44 Suppl 1():219-25.
2012: Soo-Young Lee; Jun Okuda; Ilja Peckermann; Elise Abinet; Günter Henze; Aram Prokop
The rare-earth yttrium complex [YR(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells.
Medical oncology (Northwood, London, England) 2012;29(1):235-42.
2011: Shabnam Shalapour; Arend von Stackelberg; Lorenz Bastian; Cornelia Eckert; Günter Henze; Jana Hof; Renate Kirschner-Schwabe; Javier Prada; Karl Seeger
High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
Haematologica 2011;96(11):1627-35.
2011: Jenny Lena Kanitz; Alfred Längler; Kim Pretzer; Marcus Reif; Ralf Brand; Günter Henze; Andreas Voss; Petra Warschburger; Georg Seifert
The impact of eurythmy therapy on stress coping strategies and health-related quality of life in healthy, moderately stressed adults.
Complementary therapies in medicine 2011;19(5):247-55.
2011: Jana Hof; Leonid Karawajew; Cornelia Eckert; Christian Hagemeier; Günter Henze; Gabriele Körner; Stefanie Krentz; Wolf-Dieter Ludwig; Peter Rhein; Karl Seeger; Shabnam Shalapour; Claudia van Schewick; Arend von Stackelberg; Renate Kirschner-Schwabe
Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3185-93.
2011: Cornelia Eckert; T Flohr; N Hagedorn; Günter Henze; Renate Kirschner-Schwabe; R Koehler; A Moericke; Martin Schrappe; Claus R Bartram; G Cario; Av Stackelberg; Martin Stanulla; André Schrauder
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment.
Leukemia 2011;25(8):1305-13.
2011: Georg Seifert; Günter Henze; Alfred Längler
Adverse events associated with the use of complementary and alternative medicine in children.
Archives of disease in childhood 2011;96(8):786-7.
2011: Gesche Tallen; Petra Degenhardt; Günter Henze; Pablo Hernáiz Driever; Thomas Riebel
High reliability of scrotal ultrasonography in the management of childhood primary testicular neoplasms.
Klinische Pädiatrie 2011;223(3):131-7.
2011: Christian Furth; Holger Amthauer; Hubertus Hautzel; Ingo Steffen; J Ruf; J Schiefer; Stefan Schönberger; Günter Henze; R Grandt; Patrick Hundsdoerfer; M Dietlein; C Kobe
Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre read.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(5):1198-203.
2011: Georg Seifert; Stefan Rutkowski; Patrick Jesse; Rene Madeleyn; Marcus Reif; Günter Henze; Alfred Längler
Anthroposophic supportive treatment in children with medulloblastoma receiving first-line therapy.
Journal of pediatric hematology/oncology 2011;33(3):e105-8.
2011: Soo-Young Lee; Annegret Hille; Igor Kitanovic; Patrick Jesse; Günter Henze; Stefan Wölfl; Ronald Gust; Aram Prokop
[Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
Leukemia research 2011;35(3):387-93.
2011: Lindy Musial-Bright; Rüdiger Fengler; Günter Henze; Pablo Hernáiz Driever
Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2011;27(3):407-13.
2011: Dirk Cysarz; Maijana Linhard; Friedrich Edelhäuser; Alfred Längler; Peter Van Leeuwen; Günter Henze; Georg Seifert
Unexpected course of nonlinear cardiac interbeat interval dynamics during childhood and adolescence.
PloS one 2011;6(5):e19400.
2011: Arend von Stackelberg; Enrico Völzke; Jörn-Sven Kühl; Karl Seeger; André Schrauder; Gabriele Escherich; Günter Henze; Gesche Tallen
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.
European journal of cancer (Oxford, England : 1990) 2011;47(1):90-7.
2010: Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.
European journal of nuclear medicine and molecular imaging 2010;37(10):1842-53.
2010: Patrick Hundsdoerfer; Isabell Dietrich; Karin Schmelz; Cornelia Eckert; Günter Henze
XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL.
Pediatric blood & cancer 2010;55(2):260-6.
2010: Gesche Tallen; Richard Ratei; Georg Mann; Gertjan Kaspers; Felix Niggli; Alexandr Karachunsky; Wolfram Ebell; Gabriele Escherich; Martin Schrappe; Thomas Klingebiel; Ruediger Fengler; Günter Henze; Arend von Stackelberg
Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2339-47.
2010: R Rendtorff; C Hohmann; S Reinmuth; A Müller; R Dittrich; M Beyer; L Wickmann; Thomas Keil; Günter Henze; A Borgmann-Staudt
Hormone and Sperm Analyses after Chemo- and Radiotherapy in Childhood and Adolescence.
Klinische Pädiatrie 2010;222(3):145-9.
2010: Shabnam Shalapour; Cornelia Eckert; Karl Seeger; Madlen Pfau; Javier Prada; Günter Henze; Thomas Blankenstein; Thomas Kammertoens
Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia.
Journal of molecular medicine (Berlin, Germany) 2010;88(3):249-65.
2010: Stefan Mark Rueckriegel; Pablo Hernáiz Driever; Friederike Blankenburg; Lutz Lüdemann; Günter Henze; Harald Bruhn
Differences in supratentorial damage of white matter in pediatric survivors of posterior fossa tumors with and without adjuvant treatment as detected by magnetic resonance diffusion tensor imaging.
International journal of radiation oncology, biology, physics 2010;76(3):859-66.
2010: Anja Möricke; Martin Zimmermann; Alfred Reiter; Günter Henze; André Schrauder; Helmut Gadner; Wolf-Dieter Ludwig; J Ritter; Jochen Harbott; Georg Mann; Thomas Klingebiel; Felix Zintl; C Niemeyer; Bernhard Kremens; Felix Niggli; Dietrich Niethammer; Karl Welte; Martin Stanulla; E Odenwald; Hansjörg Riehm; Martin Schrappe
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
Leukemia 2010;24(2):265-84.
2010: Susanne Lucas; Günter Henze; Dirk Schnabel; Winfried Barthlen; Sadatoshi Sakuma; Andreas Kurtz; Pablo Hernáiz Driever
Serum levels of Midkine in children and adolescents without malignant disease.
Pediatrics international : official journal of the Japan Pediatric Society 2010;52(1):75-9.
2009: Susanne Lucas; Tobias Reindl; Günter Henze; Andreas Kurtz; Sadatoshi Sakuma; Pablo Hernáiz Driever
Increased midkine serum levels in pediatric embryonal tumor patients.
Journal of pediatric hematology/oncology 2009;31(10):713-7.
2009: Christian Furth; Ingo Steffen; Holger Amthauer; Juri Ruf; Daniel Misch; Stefan Schönberger; Carsten Kobe; Timm Denecke; Brigitte Stöver; Hubertus Hautzel; Günter Henze; Patrick Hundsdoerfer
Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4385-91.
2009: Patrick Hundsdoerfer; Marion Albrecht; Ursula Rühl; Rüdiger Fengler; Andreas E Kulozik; Günter Henze
Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
European journal of cancer (Oxford, England : 1990) 2009;45(14):2447-51.
2009: Stefan Mark Rueckriegel; Friederike Blankenburg; Günter Henze; Herrmann Baqué; Pablo Hernáiz Driever
Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors.
Pediatric blood & cancer 2009;53(3):424-31.
2009: Birgit Burkhardt; Alfred Reiter; Eva Landmann; Peter Lang; Lisa Lassay; Roswita Dickerhoff; Max Lakomek; Günter Henze; Arend von Stackelberg
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3363-9.
2009: Maria Lueth; Lena Wronski; Almut Giese; Renate Kirschner-Schwabe; Torsten Pietsch; Andreas von Deimling; Günter Henze; Andreas Kurtz; Pablo Hernáiz Driever
Somatic mitochondrial mutations in pilocytic astrocytoma.
Cancer genetics and cytogenetics 2009;192(1):30-5.
2009: Norihiko Kawamata; Seishi Ogawa; Karl Seeger; Renate Kirschner-Schwabe; Thien Huynh; John Chen; Nairi Megrabian; Jochen Harbott; Martin Zimmermann; Günter Henze; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
International journal of oncology 2009;34(6):1603-12.
2009: Georg Seifert; Pablo Hernáiz Driever; Kim Pretzer; Friedrich Edelhäuser; Susanne Bach; Hans-Broder V Laue; Alfred Längler; Lindy Musial-Bright; Günter Henze; Dirk Cysarz
Effects of complementary eurythmy therapy on heart rate variability.
Complementary therapies in medicine 2009;17(3):161-7.
2009: Patrick Jesse; Gritt Mottke; Jürgen Eberle; Georg Seifert; Günter Henze; Aram Prokop
Apoptosis-inducing activity of Helleborus niger in ALL and AML.
Pediatric blood & cancer 2009;52(4):464-9.
2009: Bettina Reismüller; Andishe Attarbaschi; Christina Peters; Michael N Dworzak; Ulrike Pötschger; Christian Urban; Franz-Martin Fink; Bernhard Meister; Klaus Schmitt; Karin Dieckmann; Günter Henze; Oskar A Haas; Helmut Gadner; Georg Mann
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
British journal of haematology 2009;144(4):559-70.
2008: Stefan Mark Rueckriegel; Friederike Blankenburg; Roland Burghardt; Stefan Ehrlich; Günter Henze; Roland Mergl; Pablo Hernáiz Driever
Influence of age and movement complexity on kinematic hand movement parameters in childhood and adolescence.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2008;26(7):655-63.
2008: Friederike Blankenburg; Ianina Scheer; Nanette Sarioglu; Günter Henze; Pablo Hernáiz Driever; Thomas Riebel
Spontaneous regression of a vascular tumor of the skull base--infantile hemangioendothelioma?
Journal of pediatric hematology/oncology 2008;30(9):712-5.
2008: Günter Henze
Early postinduction intensification therapy is essential in childhood acute lymphoblastic leukemia.
Nature clinical practice. Oncology 2008;5(9):502-3.
2008: Daniel Misch; Ingo Steffen; Stefan Schönberger; Thomas Voelker; Christian Furth; Brigitte Stöver; Hubertus Hautzel; Günter Henze; Holger Amthauer; Timm Denecke
Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.
European journal of nuclear medicine and molecular imaging 2008;35(9):1642-50.
2008: Joachim Köchling; Javier Prada; Masoud Bahrami; Renata Stripecke; Karl Seeger; Günter Henze; Burghardt Wittig; Manuel Schmidt
Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia.
Vaccine 2008;26(36):4669-75.
2008: Georg Seifert; Patrick Jesse; Alfred Laengler; Tobias Reindl; Maria Lüth; Stephan Lobitz; Günter Henze; Aram Prokop; Holger N Lode
Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Cancer letters 2008;264(2):218-28.
2008: S Reinmuth; A-K Liebeskind; L Wickmann; A Bockelbrink; Thomas Keil; Günter Henze; Anja Borgmann
Having children after surviving cancer in childhood or adolescence - results of a Berlin survey.
Klinische Pädiatrie 2008;220(3):159-65.
2008: Anja Möricke; Alfred Reiter; Martin Zimmermann; Helmut Gadner; Martin Stanulla; Michael Dördelmann; Lutz Löning; Rita Beier; Wolf-Dieter Ludwig; Richard Ratei; Jochen Harbott; Joachim Boos; Georg Mann; Felix Niggli; Andreas Feldges; Günter Henze; Karl Welte; Jörn D Beck; Thomas Klingebiel; Charlotte Niemeyer; Felix Zintl; Udo Bode; Christian Urban; Helmut Wehinger; Dietrich Niethammer; Hansjörg Riehm; Martin Schrappe
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
2008: Arend von Stackelberg; Reinhard Hartmann; Christoph Bührer; Rüdiger Fengler; Gritta E Janka-Schaub; Alfred Reiter; Georg Mann; Kjeld Schmiegelow; Richard Ratei; Thomas Klingebiel; Jörg Ritter; Günter Henze
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
Blood 2008;111(5):2573-80.
2008: Anja Borgmann; Christina Zinn; Reinhard Hartmann; Ralf Herold; Peter Kaatsch; Gabriele Escherich; Anja Möricke; Günter Henze; Arend von Stackelberg
Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
European journal of cancer (Oxford, England : 1990) 2008;44(2):257-68.
2007: Friederike Blankenburg; Frank K H van Landeghem; Michail Plotkin; Günter Henze; Andreas von Deimling; Pablo Hernáiz Driever
Occurrence of a spinal anaplastic pilocytic astrocytoma and a supratentorial PNET in an adolescent.
Journal of pediatric hematology/oncology 2007;29(12):832-5.
2007: Thomas Völker; Timm Denecke; Ingo Steffen; Daniel Misch; Stefan Schönberger; Michail Plotkin; Juri Ruf; Christian Furth; Brigitte Stöver; Hubertus Hautzel; Günter Henze; Holger Amthauer
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5435-41.
2007: Nikola Hagedorn; Cécile Acquaviva; Eva Fronkova; Arend von Stackelberg; Andrea Barth; Udo zur Stadt; André Schrauder; Jan Trka; Nathalie Gaspar; Karl Seeger; Günter Henze; Hélène Cavé; Cornelia Eckert
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group.
Blood 2007;110(12):4022-9.
2007: Georg Seifert; Alfred Laengler; Christoph Tautz; Karl Seeger; Günter Henze
Response to subcutaneous therapy with mistletoe in recurrent multisystem Langerhans cell histiocytosis.
Pediatric blood & cancer 2007;48(5):591-2.
2007: Almut Giese; Renate Kirschner-Schwabe; Katharina Blumchen; Lena Wronski; Shabnam Shalapour; Javier Prada; Pablo Hernáiz Driever; Martin Brauer; Markus Schuelke; Günter Henze; Karl Seeger
Prenatal manifestation of pancytopenia in Pearson marrow-pancreas syndrome caused by a mitochondrial DNA deletion.
American journal of medical genetics. Part A 2007;143(3):285-8.
2007: A I Karachunskiĭ; NV Miakova; Iu V Rumiantseva; AM Timakov; T Zh Makhortykh; LG Fechina; AV Shamardina; S A Dudkin; VV Lebedev; S R Varfolomeeva; VN Timofeeva; Ralf Herold; A Stakelberg; Günter Henze; AG Rumiantsev
[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].
Terapevticheskiĭ arkhiv 2007;79(7):19-26.
2006: Georg Seifert; Wolfram Kress; Christian Meisel; Günter Henze; Karl Seeger
Genetic investigations of Saethre-Chotzen syndrome presenting with renal cell carcinoma.
Cancer genetics and cytogenetics 2006;171(1):76-8.
2006: Christian Furth; Holger Amthauer; Timm Denecke; Juri Ruf; Günter Henze; Matthias Gutberlet
Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma.
Pediatric blood & cancer 2006;47(5):607-11.
2006: Shabnam Shalapour; Andrea Zelmer; Madlen Pfau; Eva Moderegger; Cristiane Costa-Blechschmidt; Frank K H van Landeghem; Tillmann Taube; Iduna Fichtner; Christoph Bührer; Günter Henze; Karl Seeger; Sven Wellmann
The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5526-32.
2006: Christian Furth; Timm Denecke; Ingo Steffen; Juri Ruf; Thomas Voelker; Daniel Misch; Florian Vondran; Michail Plotkin; Brigitte Stöver; Günter Henze; Arne-Jörn Lemke; Holger Amthauer
Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease.
Journal of pediatric hematology/oncology 2006;28(8):501-12.
2006: Renate Kirschner-Schwabe; Claudio Lottaz; Jörn Tödling; Peter Rhein; Leonid Karawajew; Cornelia Eckert; Arend von Stackelberg; Ute Ungethüm; Dennis Kostka; Andreas E Kulozik; Wolf-Dieter Ludwig; Günter Henze; Rainer Spang; Christian Hagemeier; Karl Seeger
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4553-61.
2006: Hagen Graf Einsiedel; L Kawan; Cornelia Eckert; O Witt; I Fichtner; Günter Henze; Karl Seeger
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Leukemia 2006;20(8):1435-6.
2006: Georg Seifert; Tobias Reindl; Stephan Lobitz; Karl Seeger; Günter Henze
Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.
Haematologica 2006;91(6 Suppl):ECR23.
2006: Shuling Wu; Reinhard Gessner; Tillmann Taube; Alexander Korte; Arend von Stackelberg; Renate Kirchner; Günter Henze; Karl Seeger
Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.
Journal of pediatric hematology/oncology 2006;28(4):216-20.
2006: Tillmann Taube; Arend von Stackelberg; Ursula Schulte-Overberg; Günter Henze; Hansjörg Schmid; Harald Reinhard
Chronic immune thrombocytopentic purpura in children: assessment of rituximab treatment.
The Journal of pediatrics 2006;148(3):423.
2006: Alexander Claviez; Cornelia Eckert; Karl Seeger; André Schrauder; Martin Schrappe; Günter Henze; Arend von Stackelberg
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Haematologica 2006;91(2):272-3.
2006: Tobias K Reindl; Wilhelm Geilen; Reinhard Hartmann; Klaus R Wiebelitz; Guishi Kan; Ilca Wilhelm; Siegfried Lugauer; Clemens Behrens; Thomas Weiberlenn; Carola Hasan; Sven Gottschling; Tanja Wild-Bergner; Günter Henze; Pablo Hernáiz Driever
Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(2):172-6.
2006: Birgit Burkhardt; Willi Woessmann; Martin Zimmermann; Udo Kontny; Josef Vormoor; Wolfgang Doerffel; Georg Mann; Günter Henze; Felix Niggli; Wolf-Dieter Ludwig; Dirk Janssen; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):491-9.
2006: Georg Seifert; Tillmann Taube; Kriztina Paal; Hagen Graf von Einsiedel; Sven Wellmann; Günter Henze; Karl Seeger; Matthias Schroff; Burghardt Wittig
Brief communication: stability and catalytic activity of novel circular DNAzymes.
Nucleosides, nucleotides & nucleic acids 2006;25(7):785-93.
2006: Georg Seifert; Hanno Riess; Karl Seeger; Günter Henze; Anja Borgmann
Intraluminal instillation of urokinase and autologous plasma: a method to unblock occluded central venous ports.
BMC cancer 2006;6():103.
2006: G Seifert; Karl Seeger; T Reindl; Thomas Voelker; Günter Henze
A metastatic alveolar rhabdomyosarcoma of the hand.
Pediatric blood & cancer 2006;46(1):115-6.
2005: Ursula Creutzig; M Zimmermann; J Ritter; Dirk Reinhardt; J Hermann; Günter Henze; H Jürgens; H Kabisch; Alfred Reiter; Hansjörg Riehm; Helmut Gadner; Günther Schellong
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Leukemia 2005;19(12):2030-42.
2005: Holger Amthauer; Christian Furth; Timm Denecke; Patrick Hundsdoerfer; Thomas Voelker; Karl Seeger; Brigitte Stöver; Günter Henze
FDG-PET in 10 children with non-Hodgkin's lymphoma: initial experience in staging and follow-up.
Klinische Pädiatrie 2005;217(6):327-33.
2005: Hagen Graf Einsiedel; Arend von Stackelberg; Reinhard Hartmann; Rüdiger Fengler; Martin Schrappe; Gritta E Janka-Schaub; Georg Mann; Karel Hählen; Ulrich Göbel; Thomas Klingebiel; Wolf-Dieter Ludwig; Günter Henze
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7942-50.
2005: Carsten Friedrich; Nikola Holtkamp; Jindrich Cinatl; Sadatoshi Sakuma; Victor-Felix Mautner; Sven Wellman; Martin Michaelis; Günter Henze; Andreas Kurtz; Pablo Hernáiz Driever
Overexpression of Midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency.
International journal of oncology 2005;27(5):1433-40.
2005: Frank Berthold; Joachim Boos; Stefan Burdach; Rudolf Erttmann; Günter Henze; Johann Hermann; Thomas Klingebiel; Bernhard Kremens; Freimut H Schilling; Martin Schrappe; Thorsten Simon; Barbara Hero
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
The lancet oncology 2005;6(9):649-58.
2005: Uta C F Nenning; Cornelia Eckert; Sven Wellmann; Andrea Barth; Günter Henze; Karl Seeger
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Journal of the National Cancer Institute 2005;97(14):1091-2; author reply 1093-5.
2005: Ursula Creutzig; Martin Zimmermann; Julia Hannemann; Irene Krämer; Beate Pfistner; Ralf Herold; Günter Henze
Quality management for clinical trials within the German Competence Network Paediatric Oncology and Haematology.
Onkologie 2005;28(6-7):333-6.
2005: G J L Kaspers; Jelle J M Wijnands; Reinhard Hartmann; Loekie Huismans; Anne H Loonen; Arend Stackelberg; Günter Henze; Rob Pieters; Karel Hählen; Elisabeth R van Wering; Anjo J P Veerman
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1300-3.
2005: Shuling Wu; Reinhard Gessner; Tillmann Taube; Arend von Stackelberg; Günter Henze; Karl Seeger
Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3038-42.
2005: Sven Wellmann; Eva Moderegger; Andrea Zelmer; M Bettkober; Arend von Stackelberg; Günter Henze; Karl Seeger
FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse.
Leukemia 2005;19(3):467-8.
2005: Shuling Wu; Reinhard Gessner; Arend von Stackelberg; Renate Kirchner; Günter Henze; Karl Seeger
Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Cancer 2005;103(5):1054-63.
2005: S Buchen; D Ngampolo; R G Melton; Carola Hasan; A Zoubek; Günter Henze; Udo Bode; Gudrun Fleischhack
Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
British journal of cancer 2005;92(3):480-7.
2005: Shuling Wu; Alexander Korte; Christian Kebelmann-Betzing; Reinhard Gessner; Günter Henze; Karl Seeger
Interaction of bone marrow stromal cells with lymphoblasts and effects of predinsolone on cytokine expression.
Leukemia research 2005;29(1):63-72.
2004: Ursula Creutzig; Heribert Jürgens; Ralf Herold; Ulrich Göbel; Günter Henze
[Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology].
Klinische Pädiatrie 2004;216(6):379-83.
2004: Arend von Stackelberg; Karl Seeger; Günter Henze; Cornelia Eckert
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
Leukemia 2004;18(10):1727-8; author reply 1728-9.
2004: Cornelia Eckert; Hagen Graf Einsiedel; Reinhard Hartmann; Arend von Stackelberg; Sigrid Völpel; Andreas Guggemos; Nikola Hanzsch; Lars Kawan; Karl Seeger; Günter Henze
Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic.
Haematologica 2004;89(7):ECR23.
2004: Tillmann Taube; Cornelia Eckert; Gabriele Körner; Günter Henze; Karl Seeger
Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia. Comparison with antigen receptor-based MRD quantification methods.
Leukemia research 2004;28(7):699-706.
2004: Peter Bader; Hermann Kreyenberg; Walter Hoelle; Gregor Dueckers; Rupert Handgretinger; Peter Lang; Bernhard Kremens; Dagmar Dilloo; Karl-Walter Sykora; Martin Schrappe; Charlotte Niemeyer; Arend von Stackelberg; Bernd Gruhn; Günter Henze; Johann Greil; Dietrich Niethammer; Klaus Dietz; James F Beck; Thomas Klingebiel
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
2004: Sven Wellmann; M Guschmann; Wanja Griethe; Cornelia Eckert; Arend von Stackelberg; Claudio Lottaz; Eva Moderegger; Hagen Graf Einsiedel; Kai-Uwe Eckardt; Günter Henze; Karl Seeger; Av Stackelberg
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.
Leukemia 2004;18(5):926-33.
2004: Gesche Tallen; Ines Kaiser; Sonja Krabbe; Ulrike Lass; Christian Hartmann; Günter Henze; Karl Riabowol; Andreas von Deimling
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.
International journal of cancer. Journal international du cancer 2004;109(3):476-9.
2003: Aram Prokop; Wolfgang Wrasidlo; Holger Lode; Ralf Herold; Florian Lang; Günter Henze; Bernd Dörken; Thomas Wieder; Peter Daniel
Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner.
Oncogene 2003;22(57):9107-20.
2003: Ursula Creutzig; Martin Zimmermann; Julia Hannemann; Irene Krämer; Ralf Herold; Günter Henze
[Quality management within the competence network of paediatric oncology and haematology].
Klinische Pädiatrie 2003;215(6):338-40.
2003: Joachim Köchling; Sven A König-Merediz; Renata Stripecke; Dirk Buchwald; Alexander Korte; Hagen G Von Einsiedel; Florian Sack; Günter Henze; Karl Seeger; Burghardt Wittig; Manuel Schmidt
Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):3142-9.
2003: Shuling Wu; Alexander Korte; Reinhard Gessner; Günter Henze; Karl Seeger
Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Cancer 2003;98(3):625-31.
2003: Frank Berthold; Barbara Hero; Bernhard Kremens; R Handgretinger; Günter Henze; Freimut H Schilling; Martin Schrappe; Thorsten Simon; Claudia Spix
Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.
Cancer letters 2003;197(1-2):11-7.
2003: Andreas Guggemos; Cornelia Eckert; Tomasz Szczepanski; Claudia Hanel; Tillmann Taube; V H J van der Velden; Hagen Graf Einsiedel; Günter Henze; Karl Seeger
Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
Haematologica 2003;88(7):737-46.
2003: Anja Borgmann; Arend von Stackelberg; Reinhard Hartmann; Wolfram Ebell; Thomas Klingebiel; Christina Peters; Günter Henze
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.
Blood 2003;101(10):3835-9.
2003: Iduna Fichtner; Krisztina Paal; Anja Borgmann; Lucia Badiali; Reinhard Wurm; Günter Henze
Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins.
Anticancer research 2003;23(3B):2657-64.
2003: Patricia Kaaijk; G J L Kaspers; Elisabeth R van Wering; GJ Broekema; Anne H Loonen; Karel Hählen; Kjeld Schmiegelow; Gritta E Janka-Schaub; Günter Henze; Ursula Creutzig; Anjo J P Veerman
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
British journal of cancer 2003;88(5):775-81.
2002: Hagen Graf Einsiedel; Tillmann Taube; Reinhard Hartmann; Sven Wellmann; Georg Seifert; Günter Henze; Karl Seeger
Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia.
Blood 2002;99(12):4629-31.
2002: Hans-Joachim Müller; Rita Beier; João Casimiro da Palma; Claudia Lanvers; Elvira Ahlke; Volker von Schütz; Martin Gunkel; Alexander Horn; Martin Schrappe; Günter Henze; Karen Kranz; Joachim Boos
PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.
Cancer chemotherapy and pharmacology 2002;49(2):149-54.
2001: Christian Kebelmann-Betzing; Karl Seeger; R Wolf; Günter Henze
Traumatic lumbar puncture at diagnosis and outcome in childhood acute lymphoblastic leukemia.
Blood 2001;98(12):3496-7.
2001: Michael Paulussen; Susanne Ahrens; M Lehnert; Dirk Taeger; HW Hense; A Wagner; Jürgen Dunst; D Harms; Alfred Reiter; Günter Henze; Charlotte Niemeyer; Ulrich Göbel; Bernhard Kremens; U R Fölsch; Walter Aulitzky; PA Voûte; Andreas Zoubek; Heribert Jürgens
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1619-30.
2001: Thomas Wieder; A Prokop; B Bagci; Frank Essmann; D Bernicke; Klaus Schulze-Osthoff; Bernd Dörken; Hans-Günther Schmalz; Peter Daniel; Günter Henze
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts.
Leukemia 2001;15(11):1735-42.
2001: Karl Seeger; Arend von Stackelberg; Tillmann Taube; D Buchwald; Gabriele Körner; Meinolf Suttorp; Wolfgang Dörffel; W Tausch; Günter Henze
Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(13):3188-93.
2001: Hagen Graf Einsiedel; Tillmann Taube; Reinhard Hartmann; Cornelia Eckert; Georg Seifert; Sven Wellmann; Günter Henze; Karl Seeger
Prognostic value of p16(INK4a) gene deletions in pediatric acute lymphoblastic leukemia.
Blood 2001;97(12):4002-4.
2001: Ursula Creutzig; J Ritter; Martin Zimmermann; Dirk Reinhardt; J Hermann; F Berthold; Günter Henze; Heribert Jürgens; H Kabisch; Werner Havers; Alfred Reiter; U Kluba; F Niggli; H Gadner
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2705-13.
2001: Karl Seeger; Tillmann Taube; Cornelia Eckert; Claudia Hanel; M Pogodda; Günter Henze
Unusual T-cell receptor-delta gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction.
British journal of haematology 2001;113(2):318-22.
2001: Joao Paulo Vieira Pinheiro; Hans-Joachim Müller; D Schwabe; Martin Gunkel; J Casimiro da Palma; Günter Henze; Volker von Schütz; M Winkelhorst; Gudrun Würthwein; Joachim Boos
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia.
British journal of haematology 2001;113(1):115-9.
2001: Sven Wellmann; Tillmann Taube; K Paal; H Graf V Einsiedel; Wilhelm Geilen; Georg Seifert; Cornelia Eckert; Günter Henze; Karl Seeger
Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology.
Clinical chemistry 2001;47(4):654-60.
2001: Karl Seeger; Karl-Anton Kreuzer; Ulrich Lass; Tillmann Taube; D Buchwald; Cornelia Eckert; Gabriele Körner; Christian A Schmidt; Günter Henze
Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
Cancer research 2001;61(6):2517-22.
2001: Karl Seeger; Susanne Viehmann; D Buchwald; Jochen Harbott; Martin Schrappe; Jan Stary; Günter Henze; Jan Trka
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL.
Leukemia 2001;15(2):280-2.
2001: Christian Kebelmann-Betzing; Gabriele Körner; Lucia Badiali; D Buchwald; A Möricke; Alexander Korte; Joachim Köchling; Shuling Wu; D Kappelmeier; K Oettel; Günter Henze; Karl Seeger
Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor all.
Cytokine 2001;13(1):39-50.
2001: Hagen Graf Einsiedel; Tillmann Taube; B Beyermann; S Dragon; A Möricke; C Kebelmann-Betzig; Joachim Köchling; Günter Henze; Karl Seeger
Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;40(3-4):413-7.
2000: Martin Schrappe; Alfred Reiter; Martin Zimmermann; Jochen Harbott; Wolf-Dieter Ludwig; Günter Henze; Helmut Gadner; E Odenwald; Hansjörg Riehm
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Leukemia 2000;14(12):2205-22.
2000: Anja Borgmann; C Baldy; A von Stackelberg; B Beyermann; Iduna Fichtner; P Nürnberg; Günter Henze
Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice.
Pediatric hematology and oncology 2000;17(8):635-50.
2000: S Reich; Christoph Bührer; Günter Henze; D Ohlendorf; M Mesche; P Sinha; Andreas Kage; C Müller; Barbara Vetter; Andreas E Kulozik
Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia.
Blood 2000;96(10):3357-63.
2000: Alexander Korte; Joachim Köchling; Lucia Badiali; Cornelia Eckert; Judit Andreae; Wilhelm Geilen; Christian Kebelmann-Betzing; Tillmann Taube; Shuling Wu; Günter Henze; Karl Seeger
Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Cytokine 2000;12(11):1597-608.
2000: A Prokop; Thomas Wieder; Isrid Sturm; Frank Essmann; K Seeger; C Wuchter; W D Ludwig; Günter Henze; B Dörken; Peter Daniel
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.
Leukemia 2000;14(9):1606-13.
2000: Hans-Joachim Müller; L Löning; Alexander Horn; D Schwabe; Martin Gunkel; Martin Schrappe; Volker von Schütz; Günter Henze; J Casimiro da Palma; J Ritter; J P Pinheiro; M Winkelhorst; Joachim Boos
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.
British journal of haematology 2000;110(2):379-84.
2000: Marianne G Rots; Rob Pieters; Godefridus J Peters; Paul Noordhuis; Christina H van Zantwijk; Günter Henze; Gritta E Janka-Schaub; Anjo J P Veerman; Gerrit Jansen
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;109(3):629-34.
2000: Martin Schrappe; Alfred Reiter; Wolf-Dieter Ludwig; Jochen Harbott; Martin Zimmermann; Wolfgang Hiddemann; Charlotte Niemeyer; Günter Henze; A Feldges; Felix Zintl; Bernhard Kornhuber; Jörg Ritter; Karl Welte; Helmut Gadner; Hansjörg Riehm
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Blood 2000;95(11):3310-22.
2000: L Löning; Martin Zimmermann; Alfred Reiter; Peter Kaatsch; Günter Henze; Hansjörg Riehm; Martin Schrappe
Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.
Blood 2000;95(9):2770-5.
2000: Cornelia Eckert; O Landt; Tillmann Taube; Karl Seeger; B Beyermann; J Proba; Günter Henze
Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia.
Leukemia 2000;14(2):316-23.
2000: Alfred Reiter; Martin Schrappe; Wolf-Dieter Ludwig; Markus Tiemann; Reza Parwaresch; Martin Zimmermann; E Schirg; Günter Henze; Günther Schellong; Helmut Gadner; Hansjörg Riehm
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood 2000;95(2):416-21.
1999: Monique L den Boer; Rob Pieters; Karin M Kazemier; Gritta E Janka-Schaub; Günter Henze; Anjo J P Veerman
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
Leukemia 1999;13(12):2023-30.
1999: Alfred Reiter; Martin Schrappe; Markus Tiemann; Wolf-Dieter Ludwig; E Yakisan; Martin Zimmermann; Georg Mann; A Chott; Wolfram Ebell; Thomas Klingebiel; Norbert Graf; Bernhard Kremens; S Müller-Weihrich; H J Plüss; Felix Zintl; Günter Henze; Hansjörg Riehm
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 1999;94(10):3294-306.
1999: A von Stackelberg; A Karatchunsky; J Kudrjashova; NV Miakova; L Belikova; A Rumiantzev; R Hartmann; Günter Henze
Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1349-55.
1999: Karl Seeger; D Buchwald; Tillmann Taube; A Peter; Arend von Stackelberg; G Schmitt; Joachim Köchling; Günter Henze
TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group.
Leukemia 1999;13(9):1469-70.
1999: Karl Seeger; D Buchwald; A Peter; Tillmann Taube; Arend von Stackelberg; G Schmitt; Günter Henze
TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia.
Blood 1999;94(1):374-6.
1999: Alexander Korte; A Möricke; B Beyermann; Joachim Köchling; Tillmann Taube; Christian Kebelmann-Betzing; Günter Henze; Karl Seeger
Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(5):495-503.
1999: S Reich; U S Overberg-Schmidt; A Leenen; Günter Henze
Neurofibromatosis 1 associated with embryonal rhabdomyosarcoma of the urinary bladder.
Pediatric hematology and oncology 1999;16(3):263-6.
1999: Ursula Creutzig; Martin Zimmermann; J Ritter; Günter Henze; N Graf; H Löffler; Günther Schellong
Definition of a standard-risk group in children with AML.
British journal of haematology 1999;104(3):630-9.
1999: Monique L den Boer; Rob Pieters; Karin M Kazemier; Gritta E Janka-Schaub; Günter Henze; Ursula Creutzig; G J L Kaspers; Pamela R Kearns; Andrew G Hall; Andrew D J Pearson; Anjo J P Veerman
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.
British journal of haematology 1999;104(2):321-7.
1998: Michael Dördelmann; Alfred Reiter; Martin Zimmermann; R Fengler; Günter Henze; Hansjörg Riehm; Martin Schrappe
Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology 1998;20(5):444-50.
1998: Wolfgang Dörffel; M Albrecht; Heike Lüders; H Marciniak; R Parwaresch; EW Schwarze; R Trauzeddel; W Havers; Günter Henze; Gritta E Janka-Schaub; Georg Mann; Charlotte Niemeyer; Richard Pötter; Günther Schellong; Barbara Selle; Jörn Treuner; Ursula Rühl
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years].
Klinische Pädiatrie 1998;210(4):212-9.
1998: Martin Schrappe; Alfred Reiter; Günter Henze; Charlotte Niemeyer; Udo Bode; Joachim Kühl; Helmut Gadner; W Havers; H Plüss; Bernhard Kornhuber; Felix Zintl; Jörg Ritter; C Urban; Dietrich Niethammer; Hansjörg Riehm
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Klinische Pädiatrie 1998;210(4):192-9.
1998: Monique L den Boer; Rob Pieters; Karin M Kazemier; Gritta E Janka-Schaub; Günter Henze; Anjo J P Veerman
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
Leukemia 1998;12(6):912-20.
1998: Monique L den Boer; Rob Pieters; Karin M Kazemier; M M A Rottier; Christian M Zwaan; G J L Kaspers; Gritta E Janka-Schaub; Günter Henze; Ursula Creutzig; Rik J Scheper; Anjo J P Veerman
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
Blood 1998;91(6):2092-8.
1998: Anja Borgmann; Arend von Stackelberg; E Baumgarten; B Uchanska-Ziegler; Andreas Ziegler; Burghardt Wittig; Günter Henze
Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment.
Journal of molecular medicine (Berlin, Germany) 1998;76(3-4):215-21.
1998: Karl Seeger; H P Adams; D Buchwald; B Beyermann; Bernhard Kremens; Charlotte Niemeyer; J Ritter; D Schwabe; D Harms; Martin Schrappe; Günter Henze
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
Blood 1998;91(5):1716-22.
1997: Jochen Harbott; Susanne Viehmann; Arndt Borkhardt; Günter Henze; Fritz H Lampert
Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.
Blood 1997;90(12):4933-7.
1997: Anja Borgmann; E Baumgarten; Hansjoerg Schmid; R Dopfer; Wolfram Ebell; Ulrich Göbel; D Niethammer; Helmut Gadner; Günter Henze
Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
Bone marrow transplantation 1997;20(11):939-44.
1997: Tillmann Taube; Karl Seeger; B Beyermann; Claudia Hanel; S Duda; C Linderkamp; Günter Henze
Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALL.
Leukemia 1997;11(11):1978-82.
1997: B Beyermann; Hans-Peter Adams; Günter Henze
Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Münster Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2231-7.
1997: A Neuendank; R Hartmann; C Bührer; B Winterhalter; E Klumper; Anjo J P Veerman; Günter Henze
Acute toxicity and effectiveness of idarubicin in childhood acute lymphoblastic leukemia.
European journal of haematology 1997;58(5):326-32.
1997: Irene Kleinau; A Perez-Canto; H J Schmid; A Grassot; Doris Staab; Harald Renz; Günter Henze; Ulrich Wahn; Karl Paul
Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;19(8):841-4.
1996: H Schmid; U von Schenck; R Hartmann; Anja Borgmann; Günter Henze
Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group.
Bone marrow transplantation 1996;18 Suppl 2():28-30.
1996: C Bührer; R Hartmann; R Fengler; B Rath; Martin Schrappe; Gritta E Janka-Schaub; Günter Henze
Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2812-7.
1996: C Bührer; Ralf Herold; D Stibenz; Günter Henze; Michael Obladen
Cerebrospinal fluid soluble L-selectin (sCD62L) in meningoencephalitis.
Archives of disease in childhood 1996;74(4):288-92.
1996: B Beyermann; Alexander Agthe; Hans-Peter Adams; Karl Seeger; C Linderkamp; G Goetze; Wolf-Dieter Ludwig; Günter Henze
Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group.
Blood 1996;87(4):1532-8.
1995: M Emeis; O Liesenfeld; Günter Henze; S Meredith; G Schoone; B Stück
[Imported visceral leishmaniasis (kala azar) in a German infant].
Klinische Pädiatrie 1995;207(6):347-9.
1995: Anja Borgmann; H Schmid; R Hartmann; E Baumgarten; K Hermann; T Klingebiel; W Ebell; F Zintl; H Gadner; Günter Henze
Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
Lancet 1995;346(8979):873-6.
1995: T Rodriguez; E Baumgarten; R Fengler; D Soumpasis; Günter Henze
[Long-term infusion of L-asparaginase--an alternative to intramuscular injection?].
Klinische Pädiatrie 1995;207(4):207-10.
1995: Anja Borgmann; R Hartmann; H Schmid; T Klingebiel; W Ebell; Ulrich Göbel; C Peters; H Gadner; Günter Henze
Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Bone marrow transplantation 1995;15(4):515-21.
1995: Alfred Reiter; Martin Schrappe; R Parwaresch; Günter Henze; S Müller-Weihrich; S Sauter; Karl-Walter Sykora; Wolf-Dieter Ludwig; Helmut Gadner; Hansjörg Riehm
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):359-72.
1994: S Belz; C Frickel; C Wolfrom; Heinz Nau; Günter Henze
High-performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid.
Journal of chromatography. B, Biomedical applications 1994;661(1):109-18.
1994: Alfred Reiter; Martin Schrappe; Wolf-Dieter Ludwig; Wolfgang Hiddemann; S Sauter; Günter Henze; Martin Zimmermann; F Lampert; W Havers; Dietrich Niethammer
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
Blood 1994;84(9):3122-33.
1994: B Lawrenz-Wolf; C Wolfrom; C Frickel; R Fengler; H Wehinger; Günter Henze
[Severe renal impairment of methotrexate elimination after high dose therapy].
Klinische Pädiatrie 1994;206(4):319-26.
1994: E Baumgarten; Hermann Herbst; M Schmitt; K H Seeger; U Schulte-Overberg; Günter Henze
Life-threatening infectious mononucleosis: is it correlated with virus-induced T cell proliferation?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):152-6.
1994: C Bührer; R Hartmann; R Fengler; S Schober; I Arlt; M Loewke; Günter Henze
Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
Blood 1994;83(12):3468-72.
1994: Nimrod Schwella; R Schwerdtfeger; V König; R Blasczyk; H Schmid; Ingo G H Schmidt-Wolf; Günter Henze; Wolfgang Siegert
Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation.
Transplantation 1994;57(8):1263-5.
1994: U Overberg-Schmidt; Rolf-Dieter Wegner; E Baumgarten; A Günther; W Ebell; H Stein; M Vogel; Günter Henze
Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia.
Cancer 1994;73(5):1522-5.
1993: H Schmid; Günter Henze; R Schwerdtfeger; E Baumgarten; A Besserer; A Scheffler; S Serke; Jürgen Zingsem; Wolfgang Siegert
Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(6):597-602.
1993: E Baumgarten; Rolf-Dieter Wegner; R Fengler; H Koch; Günter Henze
Partial trisomy 1q, an uncommon chromosomal aberration in erythroleukemia.
Leukemia & lymphoma 1993;10(3):237-40.
1993: C Bührer; U Luxenburger; Boris C Metze; E Kattner; Günter Henze; Joachim W Dudenhausen; Michael Obladen
Diminished cord blood lymphocyte L-selectin expression in neonatal bacterial infection.
European journal of pediatrics 1993;152(6):519-22.
1993: C Wolfrom; R Hartmann; R Fengler; S Brühmüller; A Ingwersen; Günter Henze
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):827-33.
1993: C Bührer; R Hartmann; R Fengler; R Dopfer; H Gadner; V Gerein; Ulrich Göbel; Alfred Reiter; J Ritter; Günter Henze
Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia.
Medical and pediatric oncology 1993;21(7):470-6.
1992: Alfred Reiter; Martin Schrappe; Wolf-Dieter Ludwig; F Lampert; Jochen Harbott; Günter Henze; C M Niemeyer; Helmut Gadner; S Müller-Weihrich; J Ritter
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Blood 1992;80(10):2471-8.
1991: Günter Henze; R Fengler; R Hartmann; B Kornhuber; Gritta E Janka-Schaub; D Niethammer; H Riehm
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Blood 1991;78(5):1166-72.
1991: H Koch; Lothar Schmitz; Konrad Brockmeier; R Hartmann; G Bein; Günter Henze
[Long-term study of anthracycline-induced cardiomyopathy in children and adolescents].
Klinische Pädiatrie 1991;203(4):262-7.
1991: C Bührer; J Atzpodien; S Oz; Günter Henze
Fosfomycin does not reduce cytostatic activity of cis-platinum against human osteosarcoma cell lines in vitro.
Pediatric hematology and oncology 1991;8(3):243-9.
1991: R Schwerdtfeger; H Schmid; H Baurmann; S Kleiner; T Zeiler; Günter Henze; Wolfgang Siegert
VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL.
Bone marrow transplantation 1991;7 Suppl 2():131.
1991: C Domeyer; U Schulte-Overberg; I Boll; E Baumgarten; C Bührer; R Fengler; Günter Henze
Erythroblastopenia in two patients after splenectomy and polychemotherapy.
The American journal of pediatric hematology/oncology 1991;13(3):320-5.
1990: Wolfgang Siegert; O Josimovic-Alasevic; R Schwerdtfeger; H Baurmann; Christian A Schmidt; R Musch; H J Schmid; R Hartmann; Günter Henze; Dieter Huhn
Soluble interleukin 2 receptors in patients after bone marrow transplantation.
Bone marrow transplantation 1990;6(2):97-101.
1990: Wolfgang Siegert; O Josimovic-Alasevic; R Schwerdtfeger; C Schmidt; A Neubauer; Günter Henze; Dieter Huhn; T Diamantstein
Determination of soluble interleukin-2 receptors after bone marrow transplantation.
Haematology and blood transfusion 1990;33():76-7.
1990: E Baumgarten; R Fengler; Konrad Brockmeier; C Domeyer; U Schulte-Overberg; H J Schmid; D Scheffner; Günter Henze
Syndrome of the posterior and anterior root in a late isolated CNS relapse of c-ALL. Case report.
Neurosurgical review 1990;13(1):73-5.
1990: D Niethammer; T Klingebiel; R Dopfer; G Ehninger; Günter Henze; W Schaefer; B Stollmann; W Ebell; M Link; Hansjörg Riehm
Allogeneic bone marrow transplantation in childhood leukemia: results and strategies in the Federal Republic of Germany.
Haematology and blood transfusion 1990;33():638-48.
1990: Günter Henze; R Fengler; R Hartmann; D Niethammer; G Schellong; Hansjörg Riehm
BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():619-26.
1990: R Fengler; R Hartmann; U Bode; G Janka; H Jürgens; Hansjörg Riehm; Günter Henze
Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():511-5.
1990: C Bührer; Günter Henze; J Hofmann; Alfred Reiter; G Schellong; Hansjörg Riehm
Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.
Haematology and blood transfusion 1990;33():500-3.
1990: Günter Henze; R Fengler; Alfred Reiter; J Ritter; Hansjörg Riehm
Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():483-8.
1990: Hansjörg Riehm; Helmut Gadner; Günter Henze; Bernhard Kornhuber; F Lampert; Dietrich Niethammer; Alfred Reiter; G Schellong
Results and significance of six randomized trials in four consecutive ALL-BFM studies.
Haematology and blood transfusion 1990;33():439-50.
1990: C Wolfrom; R Hepp; R Hartmann; H Breithaupt; Günter Henze
Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
European journal of clinical pharmacology 1990;39(4):377-83.
1989: Günter Henze; R Fengler; R Hartmann; R Dopfer; Ulrich Göbel; Norbert Graf; H Jürgens; D Niethammer; J Ritter; G Schellong
Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia.
Cancer chemotherapy and pharmacology 1989;24 Suppl 1():S16-9.
1989: E Baumgarten; Rolf-Dieter Wegner; R Fengler; Wolf-Dieter Ludwig; U Schulte-Overberg; C Domeyer; J Schüürmann; Günter Henze
Calla-positive acute leukaemia with t(5q;14q) translocation and hypereosinophilia--a unique entity?
Acta haematologica 1989;82(2):85-90.
1988: F Berthold; C Bender-Götze; R Dopfer; R Erttmann; R J Haas; Günter Henze; M Körbling; Hansjörg Riehm; M Rister; B Stollmann
[Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma].
Klinische Pädiatrie 1988;200(3):221-5.
1987: Hansjörg Riehm; A Reiter; M Schrappe; F Berthold; R Dopfer; V Gerein; R Ludwig; J Ritter; B Stollmann; Günter Henze
[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
Klinische Pädiatrie 1987;199(3):151-60.
1987: Martin Schrappe; J Beck; W E Brandeis; H J Feickert; Helmut Gadner; Norbert Graf; W Havers; Günter Henze; A Jobke; Bernhard Kornhuber
[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81].
Klinische Pädiatrie 1987;199(3):133-50.
1987: Günter Henze; S Buchmann; R Fengler; R Hartmann
The BFM relapse studies in childhood ALL: concepts of two multicenter trials and results after 2 1/2 years.
Haematology and blood transfusion 1987;30():147-55.
1986: E Baumgarten; S Buchmann; R Fengler; I Grosch-Wörner; U Schulte-Overberg; Günter Henze
[Successful chemotherapy in a primary cerebral centroblastic non-Hodgkin's lymphoma in childhood].
Onkologie 1986;9(6):290-4.
1986: R Fengler; K Pankrath; E Baumgarten; C Beck; H Becker; S Buchmann; I Grosch-Wörner; G Nessler; W Schuppert; Günter Henze
[Malignant melanoma in the child--2 case reports].
Klinische Pädiatrie 1986;198(3):245-9.
1986: Ursula Creutzig; J Ritter; M Budde; Hansjörg Riehm; Günter Henze; Fritz H Lampert; V Gerein; S Müller-Weihrich; D Niethammer; Hans J Spaar
[Current results of cooperative AML therapy studies in children: BFM-78 and 83].
Klinische Pädiatrie 1986;198(3):183-90.
1986: R Fengler; E Baumgarten; S Buchmann; Ursula Creutzig; J Harbott; R Ludwig; Günter Henze
[Biclonal leukemia O-ALL/AMoL) with 11;19 translocation and trisomy X in an 8-month-old girl].
Klinische Pädiatrie 1986;198(3):178-82.
1986: Günter Henze; R Fengler; S Buchmann
[Initial results of a study of the treatment of children with ALL recurrences].
Onkologie 1986;9(2):92-5.
1985: Ursula Creutzig; J Ritter; Hansjörg Riehm; H J Langermann; Günter Henze; Hartmut Kabisch; D Niethammer; H Jürgens; B Stollmann; U Lasson
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78.
Blood 1985;65(2):298-304.
1984: G Harten; U Stephani; Günter Henze; H J Langermann; Hansjörg Riehm; F Hanefeld
Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia.
European journal of pediatrics 1984;142(3):189-97.
1984: S Müller-Weihrich; Günter Henze; H J Langermann; E Odenwald; Hansjörg Riehm
[Childhood B-cell lymphomas and leukemias. Improvement of prognosis by a therapy developed for B-neoplasms by the BFM study group].
Onkologie 1984;7(4):205-8.
1984: S Müller-Weihrich; J Beck; Günter Henze; A Jobke; Bernhard Kornhuber; Fritz H Lampert; R Ludwig; G Prindull; G Schellong; Hans J Spaar
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage].
Klinische Pädiatrie 1984;196(3):135-42.
1984: Fritz H Lampert; Günter Henze; H J Langermann; G Schellong; Helmut Gadner; Hansjörg Riehm
Acute lymphoblastic leukemia: current status of therapy in children.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;93():159-81.
1983: E Habermalz; H J Habermalz; U Stephani; Günter Henze; Hansjörg Riehm; F Hanefeld
Cranial computed tomography of 64 children in continuous complete remission of leukemia I: relations to therapy in modalities.
Neuropediatrics 1983;14(3):144-8.
1983: Günter Henze; H J Langermann; J Brämswig; G Schellong; R Ludwig; Hansjörg Riehm
[Results of preventive management of the central nervous system in 275 children with acute lymphoblastic leukemia].
Klinische Pädiatrie 1983;195(3):168-75.
1983: Ursula Creutzig; J Ritter; H J Langermann; Hansjörg Riehm; Günter Henze; D Niethammer; Heribert Jürgens; B Stollmann; U Lasson; Hartmut Kabisch; W Wahlen; H Löffler; G Schellong
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years].
Klinische Pädiatrie 1983;195(3):152-60.
1983: Günter Henze; Fritz H Lampert; H J Langermann; G Schellong; Hansjörg Riehm
Prognosis of acute lymphoblastic leukemia related to initial findings and treatment.
Progress in clinical and biological research 1983;132D():445-9.
1983: Kurt Winkler; G Beron; Rainer Kotz; Mechthild Salzer-Kuntschik; J Beck; W Beck; W Brandeis; W Ebell; Rudolf Erttmann; Ulrich Göbel; W Havers; Günter Henze; L Hinderfield; P Höcker; A Jobke; Heribert Jürgens; Hartmut Kabisch; G Landbeck; P Preusser; G Prindull; W Ramach; J Ritter; J Sekera; J Treuner; G Wüst
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Journal of cancer research and clinical oncology 1983;106 Suppl():1-7.
1982: M Neidhardt; H J Habermalz; Günter Henze; H J Langermann
[Medulloblastoma study of the German Society for Pediatric Oncology, a first report].
Klinische Pädiatrie 1982;194(4):257-61.
1982: S Müller-Weihrich; Günter Henze; A Jobke; Bernhard Kornhuber; H J Langermann; U Lasson; R Ludwig; J Ritter; G Schellong; B Stollmann; J Treuner; Hansjörg Riehm
[BFM study 1975/81 for treatment of non-Hodgkin lymphoma of high malignancy in children and adolescents].
Klinische Pädiatrie 1982;194(4):219-25.
1982: Kurt Winkler; G Beron; G Schellong; B Stollmann; G Prindull; U Lasson; W Brandeis; Günter Henze; J Ritter; W Russe; L Stengel-Rutkowski; J Treuner; G Landbeck
[Cooperative osteosarcoma study COSS-77: results after 4 years].
Klinische Pädiatrie 1982;194(4):251-6.
1982: R Fengler; Günter Henze; H J Langermann; J Brämswig; A Jobke; Bernhard Kornhuber; R Ludwig; J Ritter; Hansjörg Riehm
[Frequency and therapy results of testicular relapse in childhood acute lymphoblastic leukemia].
Klinische Pädiatrie 1982;194(4):204-8.
1982: Günter Henze; H J Langermann; R Fengler; M Brandeis; K G Evers; Helmut Gadner; L Hinderfeld; A Jobke; Bernhard Kornhuber; Fritz H Lampert; U Lasson; R Ludwig; S Müller-Weihrich; M Neidhardt; G Nessler; D Niethammer; M Rister; J Ritter; A Schaaff; G Schellong; B Stollmann; J Treuner; W Wahlen; Peter Weinel; H Wehinger; Hansjörg Riehm
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse].
Klinische Pädiatrie 1982;194(4):195-203.
1981: K Welte; U Ebener; L Hinderfeld; J Ritter; Günter Henze; Bernhard Kornhuber
[Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)].
Klinische Pädiatrie 1981;193(3):165-71.
1981: Günter Henze; H J Langermann; J Brämswig; H Breu; Helmut Gadner; G Schellong; K Welte; Hansjörg Riehm
[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)].
Klinische Pädiatrie 1981;193(3):145-54.
1981: Günter Henze; H J Langermann; U Kaufmann; R Ludwig; G Schellong; B Stollmann; Hansjörg Riehm
Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemia.
The American journal of pediatric hematology/oncology 1981;3(4):369-76.